Back
Legend Biotech Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
30
LEGN
Legend Biotech
Last Price:
51.32
Seasonality Move:
9.49%
Sell
50
BMRN
Biomarin Pharmaceutical
Last Price:
69.82
Seasonality Move:
2.96%
Sell
30
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy, Sell or Hold?
- The current Legend Biotech [LEGN] share price is $50.31. The Score for LEGN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- LEGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $84.90. The Score for BMRN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech's stock price today?
-
The Legend Biotech share price today is $50.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEGN is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $84.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
LEGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.35 | Sell |
Relative Strength Index (14 RSI): | 37.7 | Sell |
Chaikin Money Flow: | -271494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.8 | Sell |
Relative Strength Index (14 RSI): | 40.73 | Sell |
Chaikin Money Flow: | 962873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LEGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.33 | Sell |
20-day SMA: | 54.74 | Sell |
50-day SMA: | 54.82 | Sell |
200-day SMA: | 54.28 | Sell |
8-day EMA: | 51.48 | Sell |
20-day EMA: | 53.45 | Sell |
50-day EMA: | 53.37 | Sell |
200-day EMA: | 54.23 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.29 | Sell |
20-day SMA: | 88.8 | Sell |
50-day SMA: | 86.64 | Sell |
200-day SMA: | 87.31 | Sell |
8-day EMA: | 85.7 | Sell |
20-day EMA: | 87.17 | Sell |
50-day EMA: | 86.68 | Sell |
200-day EMA: | 86.64 | Sell |
Legend Biotech Earnings Growth & LEGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.19 per share, an increase this year of $1.77 per share, and an increase next year of $0.54 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.02 per share.
Legend Biotech Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |